CHINA DASHENG BIOTECHNOLOGY COMPANY Inactive Instrument
China Dasheng Biotechnology Company Stock Other OTC
Equities
CDBT
US16944C1080
Investment Holding Companies
Financials (USD)
| Sales 2007 | 9.96M | Sales 2008 | 16.29M | Capitalization | 58.5M |
|---|---|---|---|---|---|
| Net income 2007 | 1M | Net income 2008 | 4M | EV / Sales 2007 * | - |
| Net cash position 2007 | 0.21 | Net cash position 2008 | 1.56 | EV / Sales 2008 | 3.59 x |
| P/E ratio 2007 * |
-
| P/E ratio 2008 |
13
x | Employees | - |
| Yield 2007 * |
-
| Yield 2008 |
-
| Free-Float | 61.43% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 22-07-27 | |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Frank Igwealor
DFI | Director of Finance/CFO | 53 | - |
| Chief Executive Officer | 61 | 22-07-27 |
China Dasheng Biotechnology Co. is an engine development company, precision engineering operator and transport industry equipment and service provider. The Company, through Cycclone Magnetic Engine Developments Limited, is engaged in the development and commercialization of new geometric configuration low carbon emission engines and other clean technology solutions to improve efficiency and reduce levels of greenhouse emissions. Cycclone Magnetic Engine Developments Limited operations are based in Australia.
Sector
Investment Holding Companies
| 1st Jan change | Capi. | |
|---|---|---|
| +1.89% | 1.01B | |
| +2.24% | 983M | |
| +41.91% | 872M | |
| +25.18% | 834M | |
| +1.68% | 663M | |
| +0.54% | 617M | |
| -.--% | 600M | |
| +21.02% | 560M | |
| +3.33% | 502M |
